Figure 5
CS activity corrected CIII activity and CS activity in buccal swab samples from participants of the Nijmegen Four Days Marches. (a) CIII and (c) CS in patients treated with statins (n = 60) and controls (n = 27) and (b) CIII and (d) CS in statin users with muscle complaints (n = 32), without complaints (n = 28), and non-statin users (n = 27). Activity was measured as the absorbance from the cytochrome c reduction reaction and normalised by citrate synthase (CS) activity or as CS activity alone. No statistical differences were found. Data is presented as mean ± SEM with individual data points plotted.
